Interviews | Page 10

how-pharmacists-can-implement-trigger-control-strategies-to-help-prevent-allergic-rhinitis
Dennis Williams, PharmD, FAPhA, discusses how pharmacists can help implement trigger control strategies to help prevent allergic rhinitis.
immunization-recommendations-for-special-populations
Jeffrey Goad, PharmD, MPH, FAPhA, discusses vaccine recommendations for special populations including pregnant women and health care professionals.
vaccine-recommendations-for-immunocompromised-patients
Jeffrey Goad, PharmD, MPH, FAPhA, discusses vaccine recommendations for immunocompromised patients.
how-signs-and-symptoms-of-allergic-rhinitis-differ-from-those-of-the-common-cold
Dennis Williams, PharmD, FAPhA, discusses the signs and symptoms of allergic rhinitis and how pharmacists can differentiate them from those of the common cold.
future-landscape-of-antidiabetic-agents-for-type-2-diabetes-
Susan Cornell, PharmD, CDE, FAPhA, FAADE forecasts the future landscape for antidiabetic agents recommended as a second-line treatment for type 2 diabetics.
what-must-california-pharmacists-discuss-with-patients-regarding-birth-control-
Jon Roth, CEO of the California Pharmacists Association, discusses the protocol for pharmacists when they are dispensing birth control.
successes-and-challenges-california-pharmacists-have-faced-in-dispensing-naloxone-
Jon Roth, CEO of the California Pharmacists Association, discusses the successes and challenges California pharmacists have faced in dispensing naloxone.
counseling-points-for-pharmacists-to-know-about-antidiabetic-agents-for-type-2-diabetics-
Susan Cornell, PharmD, CDE, FAPhA, FAADE discusses the patient counseling points pharmacists should be aware of for antidiabetic agents.
classes-of-antidiabetic-agents-recommended-as-second-line-therapies-for-type-2-diabetics-
Susan Cornell, PharmD, CDE, FAPhA, FAADE outlines the classes of antidiabetic agents recommended as a second-line treatment for type 2 diabetics.
promising-new-vaccines-in-the-development-pipeline
Jeffrey Goad, PharmD, MPH, FAPhA, discusses some promising new vaccines that are currently in the development pipeline.
$AD300x250BB$
Latest Issues
$auto_registration$